Target Audience

This accredited CE activity is intended for oncologists, pediatric hematologist-oncologists, nurses, and oncology social workers involved in the care of patients with hematologic malignancies. 
 

Learning Objectives

After completing this accredited CE activity, the participant should be better able to:

• Describe common childhood blood cancers, including AML and ALL 
• Identify signs and symptoms of childhood blood cancers and diagnostic tests
• Explain treatments, including the role of clinical trials, and LLS PedAL, a precision medicine clinical trial for pediatric AML
• Describe management of short- and long-term side effects of treatment and the importance of follow-up care plans
• Describe psychosocial and survivorship challenges and resources to support children and their families

Speakers

Todd Cooper, DO
Professor of Pediatrics
University of Washington
Evans Family Endowed Chair in Pediatric Cancer
Section Chief of Oncology 
Director, Leukemia/Lymphoma Program
Seattle Children's Cancer and Blood Disorders Center
Seattle, WA

Kristina Lopez, LCSW, MSW
Information Resource Specialist
Information Resource Center
The Leukemia & Lymphoma Society
Rye Brook, NY